Jonathan Edelman, senior vice president of CSL’s vaccines innovation unit, said the approval “marks a significant milestone” ...

BTIG raised the firm’s price target on Arcturus Therapeutics (ARCT) to $48 from $41 and keeps a Buy rating on the shares. The Kostaive ...

Arcturus Therapeutics (NASDAQ:ARCT – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research report issued on Friday,Benzinga reports. They currently have a $63.00 price ...

CSL Behring KK has gained approval from Japan's Ministry of Health, Labour and Welfare (MHLW) to manufacture and market ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

The Bright Agency has hired Márcia Sousa as an agent in its Children’s Illustration division. Sousa joins from the Little Tiger Group, where she was the foreign rights executive, having previously ...

If you want a CPU that has the floating point performance of a GPU, all you have to do is wait six or so years and the CPU ...

AeroVironment has launched a new variant of its Jump 20 vertical take-off and landing (VTOL) uncrewed aircraft system, with ...

Significant research news last week included a setback for Pliant Therapeutics, when it paused a Phase IIb trial of its bexotegrast in idiopathic pulmonary fibrosis (IPP). Also, US biotech AnaptysBio ...